As focus on developing therapeutic products that treat and effectively mitigate development of such diseases has gained traction, the commercial prospects have also increased.
This report aims to provide a comprehensive presentation of the global market for Microbial Therapeutic Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbial Therapeutic Product. This report contains market size and forecasts of Microbial Therapeutic Product in global, including the following market information:
Global Microbial Therapeutic Product Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Microbial Therapeutic Product market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Single Use Pre-Filled Injection/Injector Pen Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Microbial Therapeutic Product include Mylan, Roche, Novartis, Amgen Inc., Merck & Co. Inc., Biocon, Pfizer, Dr. Reddy?s Laboratories Ltd. and Intas Pharmaceuticals Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Microbial Therapeutic Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Microbial Therapeutic Product Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Microbial Therapeutic Product Market Segment Percentages, by Type, 2022 (%)
Single Use Pre-Filled Injection/Injector Pen
Multi-use Injectors
Others
Global Microbial Therapeutic Product Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Microbial Therapeutic Product Market Segment Percentages, by Application, 2022 (%)
Metabolic Disorders
Haematological Disorders
Oncology
Immunological Disorders
Infectious Diseases
Allergic Diseases
Others
Global Microbial Therapeutic Product Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Microbial Therapeutic Product Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Microbial Therapeutic Product revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Microbial Therapeutic Product revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan
Roche
Novartis
Amgen Inc.
Merck & Co. Inc.
Biocon
Pfizer
Dr. Reddy?s Laboratories Ltd.
Intas Pharmaceuticals Ltd.
Novo Nordisk A/S
Eli Lilly and Company
Sanofi S.A.
Boehringer Ingelheim
Bristol-Myers Squibb Company
Abbot Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Microbial Therapeutic Product, market overview.
Chapter 2: Global Microbial Therapeutic Product market size in revenue.
Chapter 3: Detailed analysis of Microbial Therapeutic Product company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Microbial Therapeutic Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Microbial Therapeutic Product Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Microbial Therapeutic Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Microbial Therapeutic Product Overall Market Size
2.1 Global Microbial Therapeutic Product Market Size: 2022 VS 2030
2.2 Global Microbial Therapeutic Product Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Microbial Therapeutic Product Players in Global Market
3.2 Top Global Microbial Therapeutic Product Companies Ranked by Revenue
3.3 Global Microbial Therapeutic Product Revenue by Companies
3.4 Top 3 and Top 5 Microbial Therapeutic Product Companies in Global Market, by Revenue in 2022
3.5 Global Companies Microbial Therapeutic Product Product Type
3.6 Tier 1, Tier 2 and Tier 3 Microbial Therapeutic Product Players in Global Market
3.6.1 List of Global Tier 1 Microbial Therapeutic Product Companies
3.6.2 List of Global Tier 2 and Tier 3 Microbial Therapeutic Product Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Microbial Therapeutic Product Market Size Markets, 2022 & 2030
4.1.2 Single Use Pre-Filled Injection/Injector Pen
4.1.3 Multi-use Injectors
4.1.4 Others
4.2 By Type - Global Microbial Therapeutic Product Revenue & Forecasts
4.2.1 By Type - Global Microbial Therapeutic Product Revenue, 2018-2023
4.2.2 By Type - Global Microbial Therapeutic Product Revenue, 2024-2030
4.2.3 By Type - Global Microbial Therapeutic Product Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Microbial Therapeutic Product Market Size, 2022 & 2030
5.1.2 Metabolic Disorders
5.1.3 Haematological Disorders
5.1.4 Oncology
5.1.5 Immunological Disorders
5.1.6 Infectious Diseases
5.1.7 Allergic Diseases
5.1.8 Others
5.2 By Application - Global Microbial Therapeutic Product Revenue & Forecasts
5.2.1 By Application - Global Microbial Therapeutic Product Revenue, 2018-2023
5.2.2 By Application - Global Microbial Therapeutic Product Revenue, 2024-2030
5.2.3 By Application - Global Microbial Therapeutic Product Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Microbial Therapeutic Product Market Size, 2022 & 2030
6.2 By Region - Global Microbial Therapeutic Product Revenue & Forecasts
6.2.1 By Region - Global Microbial Therapeutic Product Revenue, 2018-2023
6.2.2 By Region - Global Microbial Therapeutic Product Revenue, 2024-2030
6.2.3 By Region - Global Microbial Therapeutic Product Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Microbial Therapeutic Product Revenue, 2018-2030
6.3.2 US Microbial Therapeutic Product Market Size, 2018-2030
6.3.3 Canada Microbial Therapeutic Product Market Size, 2018-2030
6.3.4 Mexico Microbial Therapeutic Product Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Microbial Therapeutic Product Revenue, 2018-2030
6.4.2 Germany Microbial Therapeutic Product Market Size, 2018-2030
6.4.3 France Microbial Therapeutic Product Market Size, 2018-2030
6.4.4 U.K. Microbial Therapeutic Product Market Size, 2018-2030
6.4.5 Italy Microbial Therapeutic Product Market Size, 2018-2030
6.4.6 Russia Microbial Therapeutic Product Market Size, 2018-2030
6.4.7 Nordic Countries Microbial Therapeutic Product Market Size, 2018-2030
6.4.8 Benelux Microbial Therapeutic Product Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Microbial Therapeutic Product Revenue, 2018-2030
6.5.2 China Microbial Therapeutic Product Market Size, 2018-2030
6.5.3 Japan Microbial Therapeutic Product Market Size, 2018-2030
6.5.4 South Korea Microbial Therapeutic Product Market Size, 2018-2030
6.5.5 Southeast Asia Microbial Therapeutic Product Market Size, 2018-2030
6.5.6 India Microbial Therapeutic Product Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Microbial Therapeutic Product Revenue, 2018-2030
6.6.2 Brazil Microbial Therapeutic Product Market Size, 2018-2030
6.6.3 Argentina Microbial Therapeutic Product Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Microbial Therapeutic Product Revenue, 2018-2030
6.7.2 Turkey Microbial Therapeutic Product Market Size, 2018-2030
6.7.3 Israel Microbial Therapeutic Product Market Size, 2018-2030
6.7.4 Saudi Arabia Microbial Therapeutic Product Market Size, 2018-2030
6.7.5 UAE Microbial Therapeutic Product Market Size, 2018-2030
7 Microbial Therapeutic Product Companies Profiles
7.1 Mylan
7.1.1 Mylan Company Summary
7.1.2 Mylan Business Overview
7.1.3 Mylan Microbial Therapeutic Product Major Product Offerings
7.1.4 Mylan Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.1.5 Mylan Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Microbial Therapeutic Product Major Product Offerings
7.2.4 Roche Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Microbial Therapeutic Product Major Product Offerings
7.3.4 Novartis Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Amgen Inc.
7.4.1 Amgen Inc. Company Summary
7.4.2 Amgen Inc. Business Overview
7.4.3 Amgen Inc. Microbial Therapeutic Product Major Product Offerings
7.4.4 Amgen Inc. Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.4.5 Amgen Inc. Key News & Latest Developments
7.5 Merck & Co. Inc.
7.5.1 Merck & Co. Inc. Company Summary
7.5.2 Merck & Co. Inc. Business Overview
7.5.3 Merck & Co. Inc. Microbial Therapeutic Product Major Product Offerings
7.5.4 Merck & Co. Inc. Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.5.5 Merck & Co. Inc. Key News & Latest Developments
7.6 Biocon
7.6.1 Biocon Company Summary
7.6.2 Biocon Business Overview
7.6.3 Biocon Microbial Therapeutic Product Major Product Offerings
7.6.4 Biocon Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.6.5 Biocon Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Microbial Therapeutic Product Major Product Offerings
7.7.4 Pfizer Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Dr. Reddy?s Laboratories Ltd.
7.8.1 Dr. Reddy?s Laboratories Ltd. Company Summary
7.8.2 Dr. Reddy?s Laboratories Ltd. Business Overview
7.8.3 Dr. Reddy?s Laboratories Ltd. Microbial Therapeutic Product Major Product Offerings
7.8.4 Dr. Reddy?s Laboratories Ltd. Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.8.5 Dr. Reddy?s Laboratories Ltd. Key News & Latest Developments
7.9 Intas Pharmaceuticals Ltd.
7.9.1 Intas Pharmaceuticals Ltd. Company Summary
7.9.2 Intas Pharmaceuticals Ltd. Business Overview
7.9.3 Intas Pharmaceuticals Ltd. Microbial Therapeutic Product Major Product Offerings
7.9.4 Intas Pharmaceuticals Ltd. Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.9.5 Intas Pharmaceuticals Ltd. Key News & Latest Developments
7.10 Novo Nordisk A/S
7.10.1 Novo Nordisk A/S Company Summary
7.10.2 Novo Nordisk A/S Business Overview
7.10.3 Novo Nordisk A/S Microbial Therapeutic Product Major Product Offerings
7.10.4 Novo Nordisk A/S Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.10.5 Novo Nordisk A/S Key News & Latest Developments
7.11 Eli Lilly and Company
7.11.1 Eli Lilly and Company Company Summary
7.11.2 Eli Lilly and Company Business Overview
7.11.3 Eli Lilly and Company Microbial Therapeutic Product Major Product Offerings
7.11.4 Eli Lilly and Company Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.11.5 Eli Lilly and Company Key News & Latest Developments
7.12 Sanofi S.A.
7.12.1 Sanofi S.A. Company Summary
7.12.2 Sanofi S.A. Business Overview
7.12.3 Sanofi S.A. Microbial Therapeutic Product Major Product Offerings
7.12.4 Sanofi S.A. Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.12.5 Sanofi S.A. Key News & Latest Developments
7.13 Boehringer Ingelheim
7.13.1 Boehringer Ingelheim Company Summary
7.13.2 Boehringer Ingelheim Business Overview
7.13.3 Boehringer Ingelheim Microbial Therapeutic Product Major Product Offerings
7.13.4 Boehringer Ingelheim Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.13.5 Boehringer Ingelheim Key News & Latest Developments
7.14 Bristol-Myers Squibb Company
7.14.1 Bristol-Myers Squibb Company Company Summary
7.14.2 Bristol-Myers Squibb Company Business Overview
7.14.3 Bristol-Myers Squibb Company Microbial Therapeutic Product Major Product Offerings
7.14.4 Bristol-Myers Squibb Company Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.14.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.15 Abbot Laboratories
7.15.1 Abbot Laboratories Company Summary
7.15.2 Abbot Laboratories Business Overview
7.15.3 Abbot Laboratories Microbial Therapeutic Product Major Product Offerings
7.15.4 Abbot Laboratories Microbial Therapeutic Product Revenue in Global Market (2018-2023)
7.15.5 Abbot Laboratories Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Microbial Therapeutic Product Market Opportunities & Trends in Global Market
Table 2. Microbial Therapeutic Product Market Drivers in Global Market
Table 3. Microbial Therapeutic Product Market Restraints in Global Market
Table 4. Key Players of Microbial Therapeutic Product in Global Market
Table 5. Top Microbial Therapeutic Product Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Microbial Therapeutic Product Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Microbial Therapeutic Product Revenue Share by Companies, 2018-2023
Table 8. Global Companies Microbial Therapeutic Product Product Type
Table 9. List of Global Tier 1 Microbial Therapeutic Product Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Microbial Therapeutic Product Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Microbial Therapeutic Product Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Microbial Therapeutic Product Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Microbial Therapeutic Product Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Microbial Therapeutic Product Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Microbial Therapeutic Product Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Microbial Therapeutic Product Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Microbial Therapeutic Product Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Microbial Therapeutic Product Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Microbial Therapeutic Product Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Microbial Therapeutic Product Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Microbial Therapeutic Product Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Microbial Therapeutic Product Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Microbial Therapeutic Product Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Microbial Therapeutic Product Revenue, (US$, Mn), 2024-2030
Table 30. Mylan Company Summary
Table 31. Mylan Microbial Therapeutic Product Product Offerings
Table 32. Mylan Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 33. Mylan Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Microbial Therapeutic Product Product Offerings
Table 36. Roche Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Microbial Therapeutic Product Product Offerings
Table 40. Novartis Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Amgen Inc. Company Summary
Table 43. Amgen Inc. Microbial Therapeutic Product Product Offerings
Table 44. Amgen Inc. Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 45. Amgen Inc. Key News & Latest Developments
Table 46. Merck & Co. Inc. Company Summary
Table 47. Merck & Co. Inc. Microbial Therapeutic Product Product Offerings
Table 48. Merck & Co. Inc. Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 49. Merck & Co. Inc. Key News & Latest Developments
Table 50. Biocon Company Summary
Table 51. Biocon Microbial Therapeutic Product Product Offerings
Table 52. Biocon Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 53. Biocon Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Microbial Therapeutic Product Product Offerings
Table 56. Pfizer Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Dr. Reddy?s Laboratories Ltd. Company Summary
Table 59. Dr. Reddy?s Laboratories Ltd. Microbial Therapeutic Product Product Offerings
Table 60. Dr. Reddy?s Laboratories Ltd. Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 61. Dr. Reddy?s Laboratories Ltd. Key News & Latest Developments
Table 62. Intas Pharmaceuticals Ltd. Company Summary
Table 63. Intas Pharmaceuticals Ltd. Microbial Therapeutic Product Product Offerings
Table 64. Intas Pharmaceuticals Ltd. Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 65. Intas Pharmaceuticals Ltd. Key News & Latest Developments
Table 66. Novo Nordisk A/S Company Summary
Table 67. Novo Nordisk A/S Microbial Therapeutic Product Product Offerings
Table 68. Novo Nordisk A/S Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 69. Novo Nordisk A/S Key News & Latest Developments
Table 70. Eli Lilly and Company Company Summary
Table 71. Eli Lilly and Company Microbial Therapeutic Product Product Offerings
Table 72. Eli Lilly and Company Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 73. Eli Lilly and Company Key News & Latest Developments
Table 74. Sanofi S.A. Company Summary
Table 75. Sanofi S.A. Microbial Therapeutic Product Product Offerings
Table 76. Sanofi S.A. Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 77. Sanofi S.A. Key News & Latest Developments
Table 78. Boehringer Ingelheim Company Summary
Table 79. Boehringer Ingelheim Microbial Therapeutic Product Product Offerings
Table 80. Boehringer Ingelheim Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 81. Boehringer Ingelheim Key News & Latest Developments
Table 82. Bristol-Myers Squibb Company Company Summary
Table 83. Bristol-Myers Squibb Company Microbial Therapeutic Product Product Offerings
Table 84. Bristol-Myers Squibb Company Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 85. Bristol-Myers Squibb Company Key News & Latest Developments
Table 86. Abbot Laboratories Company Summary
Table 87. Abbot Laboratories Microbial Therapeutic Product Product Offerings
Table 88. Abbot Laboratories Microbial Therapeutic Product Revenue (US$, Mn) & (2018-2023)
Table 89. Abbot Laboratories Key News & Latest Developments
List of Figures
Figure 1. Microbial Therapeutic Product Segment by Type in 2022
Figure 2. Microbial Therapeutic Product Segment by Application in 2022
Figure 3. Global Microbial Therapeutic Product Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Microbial Therapeutic Product Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Microbial Therapeutic Product Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Microbial Therapeutic Product Revenue in 2022
Figure 8. By Type - Global Microbial Therapeutic Product Revenue Market Share, 2018-2030
Figure 9. By Application - Global Microbial Therapeutic Product Revenue Market Share, 2018-2030
Figure 10. By Type - Global Microbial Therapeutic Product Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Microbial Therapeutic Product Revenue Market Share, 2018-2030
Figure 12. By Application - Global Microbial Therapeutic Product Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Microbial Therapeutic Product Revenue Market Share, 2018-2030
Figure 14. By Region - Global Microbial Therapeutic Product Revenue Market Share, 2018-2030
Figure 15. By Country - North America Microbial Therapeutic Product Revenue Market Share, 2018-2030
Figure 16. US Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Microbial Therapeutic Product Revenue Market Share, 2018-2030
Figure 20. Germany Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 21. France Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Microbial Therapeutic Product Revenue Market Share, 2018-2030
Figure 28. China Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 32. India Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Microbial Therapeutic Product Revenue Market Share, 2018-2030
Figure 34. Brazil Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Microbial Therapeutic Product Revenue Market Share, 2018-2030
Figure 37. Turkey Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Microbial Therapeutic Product Revenue, (US$, Mn), 2018-2030
Figure 41. Mylan Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Amgen Inc. Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck & Co. Inc. Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Biocon Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pfizer Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Dr. Reddy?s Laboratories Ltd. Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Intas Pharmaceuticals Ltd. Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Novo Nordisk A/S Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Eli Lilly and Company Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Sanofi S.A. Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Boehringer Ingelheim Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Bristol-Myers Squibb Company Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Abbot Laboratories Microbial Therapeutic Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
